Financing Allows Company to Bring Molecular Technology to Market

ZettaCore, Inc., a developer of molecular materials and technology for current and next-generation semiconductor products, today announced that it has completed raising $21 million in a Series C financing that will allow the company to bring its technology to market. New investors Globis Capital Partners, Itochu Technology Ventures, Yasuda Enterprise Development, Epic Ventures, and Panasonic Ventures joined all previous investors: Draper Fisher Jurvetson, Kleiner Perkins Caufield + Byers, Radius Ventures, Oxford Biosciences, Access Ventures, Garrett Capital, and Stanford University.

"ZettaCore's molecular technology has the potential for broad use in the electronics industry. We were impressed with the technology's ability to further scale system level interconnect, enable high energy/power density storage in electronics and to advance Moore's law in semiconductor memory," said Satoshi Kabasawa, Councilor in the Technology Strategy Group of the Corporate R&D Strategy Office of Panasonic Corporation.

"We believe that ZettaCore's molecular technology can be an important element in our success," added Dilip Sampath, Venture Partner with Panasonic Ventures, Panasonic's U.S.-based venture capital arm. "We look forward to working with ZettaCore to find ways to integrate the technology in Panasonic's products."

"We are pleased with the progress ZettaCore has made towards commercialization of its technology. The investments from Panasonic Ventures as well as the other Japanese investors are a very good endorsement of the value of ZettaCore's technology," said Steve Jurvetson, of Draper Fisher Jurvetson, an investor in the company from its founding.

"This investment in ZettaCore will enable us to grow our business," said Subodh Toprani, ZettaCore chief executive officer. "With the new funds we will be expanding internationally, creating new product offerings and ramping commercial production of our technology."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.